News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,426 Results
Type
Article (14475)
Company Profile (105)
Press Release (266838)
Multimedia
Podcasts (66)
Webinars (13)
Section
Business (90682)
Career Advice (466)
Deals (16802)
Drug Delivery (73)
Drug Development (37492)
Employer Resources (51)
FDA (6501)
Job Trends (6405)
News (155143)
Policy (14353)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (468)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (24003)
ALS (56)
Alzheimer's disease (481)
Antibody-drug conjugate (ADC) (112)
Approvals (6696)
Artificial intelligence (208)
Autoimmune disease (42)
Automation (12)
Bankruptcy (152)
Best Places to Work (4520)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (33)
Breast cancer (190)
Cancer (1436)
Cardiovascular disease (162)
Career advice (419)
Career pathing (13)
CAR-T (53)
CDC (7)
Cell therapy (159)
Cervical cancer (9)
Clinical research (32624)
Collaboration (770)
Compensation (325)
Complete response letters (33)
COVID-19 (787)
CRISPR (44)
C-suite (440)
Cystic fibrosis (60)
Data (1940)
Denatured (18)
Depression (50)
Diabetes (135)
Diagnostics (1536)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (118)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (81)
Earnings (34858)
Editorial (21)
Employer branding (4)
Employer resources (46)
Events (39946)
Executive appointments (538)
FDA (7651)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (446)
Gene editing (72)
Generative AI (18)
Gene therapy (173)
GLP-1 (445)
Government (1420)
Grass and pollen (4)
Guidances (186)
Healthcare (3894)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (72)
Immuno-oncology (14)
Indications (53)
Infectious disease (852)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (25)
Intellectual property (116)
Interviews (60)
IPO (6272)
IRA (33)
Job creations (2088)
Job search strategy (374)
JPM (29)
Kidney cancer (9)
Labor market (28)
Layoffs (209)
Leadership (8)
Legal (3503)
Liver cancer (24)
Longevity (8)
Lung cancer (199)
Lymphoma (127)
Machine learning (13)
Management (17)
Manufacturing (426)
MASH (69)
Medical device (1606)
Medtech (1615)
Mergers & acquisitions (11036)
Metabolic disorders (450)
Multiple sclerosis (46)
NASH (15)
Neurodegenerative disease (83)
Neuropsychiatric disorders (38)
Neuroscience (901)
Neurotech (1)
NextGen: Class of 2026 (1704)
Non-profit (615)
Now hiring (17)
Obesity (234)
Opinion (143)
Ovarian cancer (40)
Pain (116)
Pancreatic cancer (55)
Parkinson's disease (81)
Partnered (11)
Patents (230)
Patient recruitment (119)
Peanut (12)
People (30066)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8568)
Phase 2 (13872)
Phase 3 (12305)
Pipeline (1988)
Policy (135)
Postmarket research (1405)
Preclinical (3520)
Press Release (26)
Prostate cancer (90)
Psychedelics (16)
Radiopharmaceuticals (143)
Rare diseases (361)
Real estate (2726)
Recruiting (19)
Regulatory (11147)
Reports (15)
Research institute (592)
Resumes & cover letters (56)
Rett syndrome (5)
RNA editing (7)
RSV (20)
Schizophrenia (71)
Series A (83)
Series B (49)
Service/supplier (2)
Sickle cell disease (49)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (11)
Startups (1689)
State (2)
Stomach cancer (5)
Supply chain (50)
Tariffs (69)
The Weekly (46)
Vaccines (234)
Venture capital (34)
Weight loss (147)
Women's health (27)
Worklife (4)
Date
Last 7 days (185)
Last 30 days (730)
Last 365 days (10934)
2026 (998)
2025 (11251)
2024 (13004)
2023 (14823)
2022 (20211)
2021 (20845)
2020 (19785)
2019 (15554)
2018 (12167)
2017 (14253)
2016 (13369)
2015 (15835)
2014 (12645)
2013 (10760)
2012 (11576)
2011 (12117)
2010 (11036)
Location
Africa (320)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (21333)
Australia (2796)
California (3366)
Canada (1537)
China (571)
Colorado (144)
Connecticut (133)
Delaware (127)
Europe (42085)
Florida (622)
Georgia (67)
Hawaii (1)
Idaho (12)
Illinois (351)
India (45)
Indiana (247)
Iowa (2)
Japan (249)
Kansas (77)
Kentucky (20)
Louisiana (6)
Maine (2)
Maryland (431)
Massachusetts (2712)
Michigan (47)
Minnesota (182)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (9)
New Jersey (1422)
New Mexico (8)
New York (966)
North Carolina (625)
North Dakota (3)
Northern California (1524)
Ohio (102)
Oklahoma (5)
Oregon (18)
Pennsylvania (753)
Puerto Rico (12)
Rhode Island (17)
South America (523)
South Carolina (10)
Southern California (1487)
Tennessee (91)
Texas (473)
United States (13285)
Utah (64)
Virginia (160)
Washington D.C. (42)
Washington State (241)
West Virginia (1)
Wisconsin (42)
Wyoming (1)
281,426 Results for "synergy pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Skye’s CB1 Inhibitor Shows ‘Intriguing Synergy’ With Wegovy, Despite Mid-Stage Obesity Fail
Skye Bioscience’s nimacimab fell short of investor and company expectations, but showed encouraging weight-loss results when combined with Wegovy, according to analysts at William Blair.
October 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
December 8, 2025
·
7 min read
Press Releases
First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
November 14, 2025
·
3 min read
Genetown
Phio Pharmaceuticals Presents Preclinical Data Demonstrating Synergy-Enhanced in vivo Anti-Tumor Efficacy of PD-1/CTLA-4 Dual-Targeting INTASYL
Phio Pharmaceuticals Corp. today announced that in vivo data from a mouse model of colon cancer demonstrates target synergy-enhanced anti-tumor efficacy from a novel dual-targeting mouse PD-1 and CTLA-4 of an INTASYL coformulation.
April 18, 2023
·
4 min read
BioForest
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
Pattern Computer®, Inc. proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer program.
May 22, 2024
·
3 min read
Press Releases
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
January 27, 2026
·
7 min read
Press Releases
Kiniksa Pharmaceuticals Provides Corporate Update
January 12, 2026
·
11 min read
Press Releases
CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines
December 10, 2024
·
4 min read
Press Releases
Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 6, 2026
·
1 min read
Press Releases
Kye Pharmaceuticals Announces Licensing and Distribution Agreement with Neurim Pharmaceuticals for SLENYTO® in Canada
January 13, 2026
·
5 min read
1 of 28,143
Next
